Autolus Therapeutics (AUTL) Other Non-Current Liabilities (2021 - 2026)
Autolus Therapeutics (AUTL) recorded Other Non-Current Liabilities of $474,000 in Q2 2026, down 0.6% from $477,000 a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Autolus Therapeutics reported Other Non-Current Liabilities of $477,000, up 12.0% from FY2024.
- Annual Other Non-Current Liabilities has increased for three straight years, with a four-year compound annual growth rate of 38.9% (FY2021 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $426,000 in FY2024 (+19.3%), $357,000 in FY2023 (+207.8%), $116,000 in FY2022 (-9.4%) and $128,000 in FY2021.
- Quarterly Other Non-Current Liabilities has ranged from $105,000 in Q3 2022 to $477,000 in Q4 2025 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities rose in six of the last seven quarters, with growth averaging 15.9%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 258.8% in Q1 2024, against a decline of 9.4% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Autolus Therapeutics | 328.71 Mn | -770.49 Mn | 25.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 474,000.00 |
| Dec 31, 2025 | 477,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 477,000.00 |
| Mar 31, 2025 | 444,000.00 |
| Dec 31, 2024 | 426,000.00 |
| Sep 30, 2024 | 447,000.00 |
| Jun 30, 2024 | 415,000.00 |
| Mar 31, 2024 | 409,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 114,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 128,000.00 |
API Access
Autolus Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();